| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INDIRECT ACCOUNTING FEES | 1,150 | 1,150 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| ABBVIE INC | 2021-02 | PURCHASE | 2023-11 | 4,154 | 3,130 | 1,024 | ||||
| BARNES & NOBLE EDUCATION | 2021-09 | PURCHASE | 2023-08 | 330 | 2,006 | -1,676 | ||||
| CHEGG INC | 2021-09 | PURCHASE | 2023-08 | 405 | 2,976 | -2,571 | ||||
| COURSERA INC | 2021-09 | PURCHASE | 2023-08 | 1,567 | 3,780 | -2,213 | ||||
| LIVE NATION ENTRTMNT | 2020-01 | PURCHASE | 2023-11 | 5,859 | 4,992 | 867 | ||||
| VERTIV HOLDINGS CO | 2020-11 | PURCHASE | 2023-12 | 2,426 | 930 | 1,496 | ||||
| WW INTL INC | 2020-11 | PURCHASE | 2023-05 | 824 | 2,551 | -1,727 | ||||
| INTELLIGENT MEDICINE UTS | 2021-12 | PURCHASE | 2023-01 | 1,033 | 1,025 | 8 | ||||
| ONCOCYTE CORP | 2016-01 | PURCHASE | 2023-07 | 1 | 21 | -20 | ||||
| OUSTER INC | 2020-12 | PURCHASE | 2023-02 | 1 | -1 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| SCHWAB 1119 | 264,828 | 213,186 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| SCHWAB - ETF | AT COST | 4,428 | 5,289 |
| SCHWAB - OTHER ASSETS | AT COST | 10,621 | 8,081 |
| Description | Amount |
|---|---|
| SCHWAB ADJ | 588 |
| Description | Beginning of Year - Book Value | End of Year - Book Value |
|---|---|---|
| CASH OVERDRAFT | 90 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAXES | 157 | 157 | ||
| FORM 4720 TAX | 38 |